HACE1 and liver cancer: For instance, HACE1 deficiency increases the proliferative and metastatic capabilities of liver cancer cells and is associated with malignant pathological features and poor patient survival rates 9 Moreover, HACE1 exerts tumor-suppressive effects in digestive tract malignancies such as colorectal cancer 10 and gastric cancer 11.